KAI Pharmaceuticals Director of Finance Salaries in Baltimore, MD | Comparably
KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
89

KAI Pharmaceuticals Director of Finance Salaries in Baltimore, MD

The average KAI Pharmaceuticals Director of Finance in Baltimore, MD earns an estimated $129,764 annually. KAI Pharmaceuticals' Director of Finance compensation is $32,252 less than the US average for a Director of Finance.

In Baltimore, MD, The Finance Department at KAI Pharmaceuticals earns $5,194 more on average than the Operations Department.

Last updated 5 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$129,764
Average Compensation
$129,764
avg. base

Director of Finance Salaries at KAI Pharmaceuticals

In Baltimore, MD, Directors of Finance earn $13,784 more than Accounting Managers.

Accounting Manager
$116k*
Business Analyst
$92k*
Financial Analyst
$87k*
Senior Accountant
$80k*
Accountant
$67k*
* estimated salary

Compensation at KAI Pharmaceuticals by Department

In Baltimore, MD, The Finance Department averages $5,194 more than the Operations Department, and $9,915 less than the Business Development Department

Business Development
$92,799 Avg. total comp.
+$10k
Finance
$82,884 Avg. total comp.
Operations
$77,690 Avg. total comp.
-$5k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to KAI Pharmaceuticals reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to KAI Pharmaceuticals reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at KAI Pharmaceuticals Rate Their Compensation

The majority of Directors of Finance at KAI Pharmaceuticals believe they're compensated fairly. 100% of Directors of Finance at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals

×
Rate your company